{"name":"Ampersand Capital Partners","permalink":"ampersand-ventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/ampersand-ventures","homepage_url":"http://www.ampersandcapital.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"781-239-0700 ","description":"","email_address":"info@ampersandcapital.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Wed Jan 30 11:46:32 UTC 2008","updated_at":"Thu Apr 21 06:04:32 UTC 2011","overview":"<p><a href=\"http://www.ampersandventures.com/\" title=\"Ampersand\" rel=\"nofollow\">Ampersand</a> is a middle market private equity firm focused on investments in two core sectors: Healthcare and Industrial.</p>","image":{"available_sizes":[[[150,43],"assets/images/resized/0002/2837/22837v1-max-150x150.jpg"],[[208,60],"assets/images/resized/0002/2837/22837v1-max-250x250.jpg"],[[208,60],"assets/images/resized/0002/2837/22837v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"55 William St.","address2":"Ste. 240","zip_code":"02481","city":"Wellesley","state_code":"MA","country_code":"USA","latitude":42.317953,"longitude":-71.229669}],"relationships":[],"investments":[{"funding_round":{"round_code":"c","source_url":"http://www.allbusiness.com/banking-finance/financial-markets-investing/5660707-1.html","source_description":"","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2004,"funded_month":6,"funded_day":1,"company":{"name":"Endeca","permalink":"endeca","image":{"available_sizes":[[[141,79],"assets/images/resized/0000/3352/3352v1-max-150x150.png"],[[141,79],"assets/images/resized/0000/3352/3352v1-max-250x250.png"],[[141,79],"assets/images/resized/0000/3352/3352v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.news.com/Endeca-lands-15-million/2110-1017_3-273769.html","source_description":"","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2001,"funded_month":11,"funded_day":1,"company":{"name":"Endeca","permalink":"endeca","image":{"available_sizes":[[[141,79],"assets/images/resized/0000/3352/3352v1-max-150x150.png"],[[141,79],"assets/images/resized/0000/3352/3352v1-max-250x250.png"],[[141,79],"assets/images/resized/0000/3352/3352v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://venturebeat.com/2008/01/14/firstrain-raises-136m-for-investment-research/","source_description":"FirstRain raises $13.6M for investment research","raised_amount":13600000,"raised_currency_code":"USD","funded_year":2008,"funded_month":1,"funded_day":14,"company":{"name":"FirstRain","permalink":"firstrain","image":{"available_sizes":[[[122,39],"assets/images/resized/0003/4386/34386v1-max-150x150.jpg"],[[122,39],"assets/images/resized/0003/4386/34386v1-max-250x250.jpg"],[[122,39],"assets/images/resized/0003/4386/34386v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.cequentpharma.com/NovartisRelease.pdf","source_description":"Cequent Pharmaceuticals","raised_amount":9000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":18,"company":{"name":"Cequent Pharmaceuticals","permalink":"cequent-pharmaceuticals","image":{"available_sizes":[[[150,41],"assets/images/resized/0006/6015/66015v1-max-150x150.png"],[[250,69],"assets/images/resized/0006/6015/66015v1-max-250x250.png"],[[299,83],"assets/images/resized/0006/6015/66015v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.sec.gov/Archives/edgar/data/1123899/000118143110012517/xslFormDX01/primary_doc.xml","source_description":"SEC D","raised_amount":7296727,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":1,"company":{"name":"FirstRain","permalink":"firstrain","image":{"available_sizes":[[[122,39],"assets/images/resized/0003/4386/34386v1-max-150x150.jpg"],[[122,39],"assets/images/resized/0003/4386/34386v1-max-250x250.jpg"],[[122,39],"assets/images/resized/0003/4386/34386v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":18690000,"raised_currency_code":"USD","funded_year":2006,"funded_month":4,"funded_day":27,"company":{"name":"FirstRain","permalink":"firstrain","image":{"available_sizes":[[[122,39],"assets/images/resized/0003/4386/34386v1-max-150x150.jpg"],[[122,39],"assets/images/resized/0003/4386/34386v1-max-250x250.jpg"],[[122,39],"assets/images/resized/0003/4386/34386v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.prweb.com/releases/2011/03/prweb5129194.htm","source_description":"Blue Sky Biotech Announces New Investment with Ampersand Ventures","raised_amount":null,"raised_currency_code":"USD","funded_year":2011,"funded_month":3,"funded_day":4,"company":{"name":"Blue Sky Biotech","permalink":"blue-sky-biotech","image":{"available_sizes":[[[144,53],"assets/images/resized/0012/5124/125124v1-max-150x150.png"],[[144,53],"assets/images/resized/0012/5124/125124v1-max-250x250.png"],[[144,53],"assets/images/resized/0012/5124/125124v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020110427e74s0015p&r=Rss&s=DJFVW","source_description":"Nitinol Devices Raises $20M From Ampersand","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":4,"funded_day":28,"company":{"name":"NDC","permalink":"ndc","image":{"available_sizes":[[[131,73],"assets/images/resized/0013/2347/132347v1-max-150x150.jpg"],[[131,73],"assets/images/resized/0013/2347/132347v1-max-250x250.jpg"],[[131,73],"assets/images/resized/0013/2347/132347v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.nitinol.com/company/newsroom/News/NDC-Raises-Growth-Capital-from-Ampersand-533/","source_description":"NDC Raises Growth Capital from Ampersand ","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":4,"funded_day":26,"company":{"name":"Nitinol Devices & Components","permalink":"nitinol-devices-components","image":{"available_sizes":[[[107,53],"assets/images/resized/0013/2349/132349v1-max-150x150.png"],[[107,53],"assets/images/resized/0013/2349/132349v1-max-250x250.png"],[[107,53],"assets/images/resized/0013/2349/132349v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}